News
-
-
PRESS RELEASE
Edison issues review on BB Biotech (BION): A recovering sector with a healthy prognosis
Edison issues review on BB Biotech (BION), highlighting its performance improvement and optimistic outlook in the recovering biotech sector, offering investors an opportunity for acquisition at an attractive level -
PRESS RELEASE
Lethally RSV Infected Animals Orally Treated with NV-387 Showed Normal Lung Histology, Indicating Potential Cure
NanoViricides, Inc. announces strong antiviral activity of NV-387 against RSV, Influenza A, and Coronaviruses in lethal lung infection models, potentially offering a cure for RSV infection -
-
-
PRESS RELEASE
Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Axway Software discloses total voting rights and shares as of April 30, 2024, in compliance with French regulations. Learn more about Axway and its offerings at investors.axway.com/en -
-
-
PRESS RELEASE
Quadient Positioned as Leader in 2024 SPARK Matrix for Accounts Receivable Applications for Third Consecutive Year
Quadient named Technology Leader in 2024 SPARK Matrix for Accounts Receivable Applications for third consecutive year. Recognized for innovative AR solutions and market leadership -
